Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: Results from the MONICA/ KDRA study

Thrombosis and Haemostasis

Volumn 101, Issue 2, 2009, Pages 317-324

  Kolz, Melanie ^a   Baumert, Jens ^a   Gohlke, Henning ^a   Grallert, Harald ^a   Döring, Angela ^a   Peters, Annette ^a   Wichmann, H Erich ^a,b   Koenig, Wolfgang ^c   Illig, Thomas ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Fibrinogen; Genetics; Haplotypes; Hypertension

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); FEMALE; FIBRINOGEN BLOOD LEVEL; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GERMANY; HEALTH SURVEY; MIDDLE AGED; MULTIGENE FAMILY; PATHOPHYSIOLOGY; PHENOTYPE;

ADULT; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HAPLOTYPES; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIGENE FAMILY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEX FACTORS; YOUNG ADULT;

EID: 62449107237     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-06-0411     Document Type: Article

References (33)

1. Schneider DJ, Taatjes DJ, Howard DB, et al. Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein; a potential contributor to cardiovascular risk. J Am Coll Cardiol 1999; 33: 261-266.
2. Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992; 94:93-107.
3. Nesbitt JE, Fuller GM. Transcription and translation are required for fibrinogen mRNA degradation in hepatocytes. Biochim Biophys Acta 1991: 1089: 88-94.
4. Yu S, Sher B. Kudryk B, et al. Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem 1984:259: 10574-10581.
5. Koenig W. Fibrin(ogen) in cardiovascular disease; an update. Thromb Haemost 2003; 89: 601-609.
6. de Lange M, de Geus EJ, Kluft C, et al. Genetic influences on fibrinogen, tissue plasminogen activatorantigen and von Willebrand factor in males and females. Thromb Haemost 2006; 95: 414-419.
7. Green FR. Fibrinogen polymorphisms and atherothrombotic disease. Ann NY Acad Sci 2001; 936: 549-559.
8. Iacoviello L, Vischetti M, Zito F. et al. Genes encoding fibrinogen and cardiovascular risk. Hypertension 2001; 38: 1199-1203.
9. Carry CL, Cushman M, Jones D, et al. Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost 2008; 99: 388-395.
10. Mannila MN, Eriksson P, Lundman P, et al. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 2005; 93: 570-577.
11. Reiner AP, Carry CL, Carlson CS, et al. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost 2006; 4: 1279-1287.
12. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 2005; 106: 4176-4183.
13. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809.
14. Behague I, Poirier O, Nicaud V, et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996;93:440-449.
15. Kardys I, Uitterlinden AG, Holrnan A, et al. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study. Thromb Haemost 2007; 97: 288-295.
16. Lawlor DA, Smith GD, Rumley A, et al. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. Thromb Haemost 2005; 93: 955-963.
17. Folsom AR, Peacock JM, Nieto FJ, et al. Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens 1998; 16: 1579-1583.
18. Shankar A, Wang JJ, Rochtchina E, et al. Positive association between plasma fibrinogen level and incident hypertension among men: population-based cohort study. Hypertension 2006; 48: 1043-1049.
19. Lee AJ, Lowe GD, Woodward M, et al. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 69: 338-342.
20. Eliasson M, Evrin PE, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study. I Clin Epidemiol 1994; 47: 513-524.
21. Green D, Ruth KJ, Folsom AR, et al. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 1994; 14: 686-693.
22. Fowkes FG, Lowe GD, Rumley A, et al. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur.Heart J 1993; 14: 597-601.
23. Wichmann HE, Gieger C, Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67 (Suppl 1): S26-S30.
24. Lowel H, Doring A, Schneider A, et al. The MONICA Augsburg surveys - basis for prospective cohort studies. Gesundheitswesen 2005; 67 (Suppl 1): S13-S18.
25. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189.
26. Kirkendall WM, Feinleib M, Freis ED, et al. Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Hypertension 1981;3:510A-519A.
27. Hense HW, Kuulasmaa K, Zaborskis A, et al. Quality assessment of blood pressure measurements in epidemiological surveys. The impact of last digit preference and the proportions of identical duplicate measurements. WHO Monica Project. Rev Epidemiol Sante Publique 1990; 38: 463-468.
28. Weidinger S, Klopp N, Wagenpfeil S, et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004; 41: 658-663.
29. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921-927.
30. Wang N, Akey JM, Zhang K, et al. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet 2002; 71: 1227-1234.
31. Verschuur M, de Jong M, Felida L, et al. A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. J Biol Chem 2005; 280: 16763-16771.
32. Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood 1998; 92: 3286-3293.
33. Lovely RS, Falls LA, Al Mondhiry HA, et al. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31.